Core Viewpoint - The article discusses the recent contract signed by Akoli with Wuxi Dacheng High-tech Materials Co., Ltd. for the sale of cyclic olefin copolymer (COC), highlighting the company's efforts to expand its market presence and the challenges it faces in the competitive landscape of the polymer industry [2][3]. Group 1: Company Developments - Akoli signed a sales contract with Wuxi Dacheng for COC, with a total transaction amount of RMB 2.6 million, to be delivered in four batches from September to December 2025 [2]. - Wuxi Dacheng is a subsidiary of Akoli, focusing on the development and production of pharmaceutical-grade COC materials [2]. - The pricing of the COC products is based on production costs and market conditions, ensuring fairness and no harm to shareholders [2]. Group 2: Market Analysis - The domestic demand for COC/COP is projected to reach 45,000 tons by 2025, with a compound annual growth rate (CAGR) of 18.9% [3]. - Akoli's revenue for the first half of 2025 was RMB 213.96 million, a decrease of 11.63% year-on-year, with a net profit attributable to shareholders of -RMB 5.31 million, down 367.84% [3][6]. - The decline in revenue and profit is attributed to decreased sales volume and prices of its main product, polyether amine, particularly in the wind power sector [3][6]. Group 3: Strategic Initiatives - In response to increased competition in the domestic wind power market, Akoli is actively exploring international markets and enhancing sales in the oil and gas sector [5]. - The company is also expanding its market share in the automotive coatings sector with optical-grade polymer materials [5]. - Akoli's production line for high-transparency materials (COC) has completed trial production and is now in formal production, with initial products being tested by downstream clients [5].

Core Viewpoint - The company, Wuxi Akoli Technology Co., Ltd., has provided a comprehensive report on its fundraising activities and operational performance for the first half of 2025, highlighting its financial management, project updates, and commitment to shareholder returns [4][25][36]. Group 1: Fundraising and Financial Management - The company raised a total of 215,179,854.12 RMB through a private placement of 7,762,621 shares at a price of 27.72 RMB per share, with a net amount of 207,313,142.47 RMB after deducting issuance costs [4][5]. - The funds were deposited into designated accounts as per regulatory requirements, with agreements established for the management of these funds [6][7]. - As of June 30, 2025, the company reported no idle funds being used to temporarily supplement working capital [9]. Group 2: Project Updates - The company is currently working on a project to produce 20,000 tons of polyether amine, which has been delayed due to compliance issues with safety regulations, pushing the expected completion date from December 2024 to December 2025 [14][15]. - A new project for producing 2,000 tons of special cooling liquid has been registered, with a total investment of 20 million RMB and planned to commence construction in October 2025 [20][21]. Group 3: Operational Performance - The company has emphasized its focus on optimizing its core business structure and enhancing operational efficiency, particularly in the fields of polyether amine and optical-grade polymer materials [36][37]. - The company has maintained a consistent dividend policy, distributing a total of approximately 119 million RMB in cash dividends over the past five years, with a recent distribution of 9,570,012.10 RMB for the 2024 fiscal year [38]. Group 4: Governance and Investor Relations - The company has adhered to governance standards, holding multiple board meetings and ensuring compliance with legal requirements [40]. - The company has committed to transparent communication with investors, having disclosed 2 regular reports and 43 interim announcements in the first half of 2025 [41].